Logo image of RPAY

REPAY HOLDINGS CORP (RPAY) Stock Fundamental Analysis

NASDAQ:RPAY - Nasdaq - US76029L1008 - Common Stock - Currency: USD

5.11  +0.16 (+3.23%)

After market: 5.11 0 (0%)

Fundamental Rating

4

RPAY gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 99 industry peers in the Financial Services industry. RPAY scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. RPAY may be a bit undervalued, certainly considering the very reasonable score on growth


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year RPAY was profitable.
RPAY had a positive operating cash flow in the past year.
RPAY had negative earnings in 4 of the past 5 years.
In the past 5 years RPAY always reported a positive cash flow from operatings.
RPAY Yearly Net Income VS EBIT VS OCF VS FCFRPAY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M 150M

1.2 Ratios

The Return On Assets of RPAY (-0.84%) is worse than 83.84% of its industry peers.
The Return On Equity of RPAY (-1.71%) is worse than 80.81% of its industry peers.
Industry RankSector Rank
ROA -0.84%
ROE -1.71%
ROIC N/A
ROA(3y)-2.38%
ROA(5y)-3.92%
ROE(3y)-4.49%
ROE(5y)-7.98%
ROIC(3y)N/A
ROIC(5y)N/A
RPAY Yearly ROA, ROE, ROICRPAY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 -5 -10 -15 -20

1.3 Margins

With an excellent Gross Margin value of 77.03%, RPAY belongs to the best of the industry, outperforming 85.86% of the companies in the same industry.
RPAY's Gross Margin has been stable in the last couple of years.
RPAY does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 77.03%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.07%
GM growth 5Y0.49%
RPAY Yearly Profit, Operating, Gross MarginsRPAY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

5

2. Health

2.1 Basic Checks

RPAY does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for RPAY has been reduced compared to 1 year ago.
The number of shares outstanding for RPAY has been increased compared to 5 years ago.
Compared to 1 year ago, RPAY has a worse debt to assets ratio.
RPAY Yearly Shares OutstandingRPAY Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
RPAY Yearly Total Debt VS Total AssetsRPAY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

Based on the Altman-Z score of 0.37, we must say that RPAY is in the distress zone and has some risk of bankruptcy.
RPAY has a Altman-Z score of 0.37. This is comparable to the rest of the industry: RPAY outperforms 46.46% of its industry peers.
RPAY has a debt to FCF ratio of 5.96. This is a neutral value as RPAY would need 5.96 years to pay back of all of its debts.
RPAY has a better Debt to FCF ratio (5.96) than 61.62% of its industry peers.
RPAY has a Debt/Equity ratio of 0.66. This is a neutral value indicating RPAY is somewhat dependend on debt financing.
RPAY's Debt to Equity ratio of 0.66 is in line compared to the rest of the industry. RPAY outperforms 53.54% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF 5.96
Altman-Z 0.37
ROIC/WACCN/A
WACC6.2%
RPAY Yearly LT Debt VS Equity VS FCFRPAY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

RPAY has a Current Ratio of 3.71. This indicates that RPAY is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 3.71, RPAY belongs to the top of the industry, outperforming 85.86% of the companies in the same industry.
RPAY has a Quick Ratio of 3.71. This indicates that RPAY is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 3.71, RPAY belongs to the best of the industry, outperforming 86.87% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.71
Quick Ratio 3.71
RPAY Yearly Current Assets VS Current LiabilitesRPAY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

5

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 1.11% over the past year.
Measured over the past 5 years, RPAY shows a small growth in Earnings Per Share. The EPS has been growing by 3.49% on average per year.
Looking at the last year, RPAY shows a small growth in Revenue. The Revenue has grown by 2.26% in the last year.
RPAY shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 24.51% yearly.
EPS 1Y (TTM)1.11%
EPS 3Y3.49%
EPS 5YN/A
EPS Q2Q%-4.35%
Revenue 1Y (TTM)2.26%
Revenue growth 3Y12.6%
Revenue growth 5Y24.51%
Sales Q2Q%-4.21%

3.2 Future

The Earnings Per Share is expected to grow by 3.51% on average over the next years.
The Revenue is expected to grow by 3.49% on average over the next years.
EPS Next Y-5.68%
EPS Next 2Y3.11%
EPS Next 3Y3.51%
EPS Next 5YN/A
Revenue Next Year-3.49%
Revenue Next 2Y2.22%
Revenue Next 3Y3.49%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
RPAY Yearly Revenue VS EstimatesRPAY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
RPAY Yearly EPS VS EstimatesRPAY Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

7

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 5.62, which indicates a rather cheap valuation of RPAY.
Based on the Price/Earnings ratio, RPAY is valued cheaply inside the industry as 88.89% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 26.46, RPAY is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 5.22, the valuation of RPAY can be described as very cheap.
Based on the Price/Forward Earnings ratio, RPAY is valued cheaply inside the industry as 86.87% of the companies are valued more expensively.
RPAY is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.30, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 5.62
Fwd PE 5.22
RPAY Price Earnings VS Forward Price EarningsRPAY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, RPAY is valued a bit cheaper than the industry average as 74.75% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, RPAY is valued cheaper than 93.94% of the companies in the same industry.
Industry RankSector Rank
P/FCF 5.78
EV/EBITDA 8.59
RPAY Per share dataRPAY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y3.11%
EPS Next 3Y3.51%

0

5. Dividend

5.1 Amount

No dividends for RPAY!.
Industry RankSector Rank
Dividend Yield N/A

REPAY HOLDINGS CORP

NASDAQ:RPAY (6/3/2025, 8:00:02 PM)

After market: 5.11 0 (0%)

5.11

+0.16 (+3.23%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)05-12 2025-05-12/amc
Earnings (Next)08-06 2025-08-06/amc
Inst Owners100.28%
Inst Owner Change-1.05%
Ins Owners6.11%
Ins Owner Change6.18%
Market Cap482.95M
Analysts76.47
Price Target9.18 (79.65%)
Short Float %8.66%
Short Ratio3.18
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-3.88%
Min EPS beat(2)-5.01%
Max EPS beat(2)-2.76%
EPS beat(4)1
Avg EPS beat(4)-2.84%
Min EPS beat(4)-5.01%
Max EPS beat(4)0.14%
EPS beat(8)3
Avg EPS beat(8)0.95%
EPS beat(12)5
Avg EPS beat(12)0.46%
EPS beat(16)8
Avg EPS beat(16)3.65%
Revenue beat(2)1
Avg Revenue beat(2)-3.33%
Min Revenue beat(2)-6.77%
Max Revenue beat(2)0.11%
Revenue beat(4)1
Avg Revenue beat(4)-3.02%
Min Revenue beat(4)-6.77%
Max Revenue beat(4)0.11%
Revenue beat(8)4
Avg Revenue beat(8)-0.21%
Revenue beat(12)7
Avg Revenue beat(12)0.09%
Revenue beat(16)9
Avg Revenue beat(16)0.2%
PT rev (1m)-3.88%
PT rev (3m)-19.18%
EPS NQ rev (1m)-4.86%
EPS NQ rev (3m)-10.31%
EPS NY rev (1m)-4.57%
EPS NY rev (3m)-12.39%
Revenue NQ rev (1m)-0.15%
Revenue NQ rev (3m)-6.1%
Revenue NY rev (1m)-0.83%
Revenue NY rev (3m)-8.01%
Valuation
Industry RankSector Rank
PE 5.62
Fwd PE 5.22
P/S 1.56
P/FCF 5.78
P/OCF 3.78
P/B 0.64
P/tB N/A
EV/EBITDA 8.59
EPS(TTM)0.91
EY17.81%
EPS(NY)0.98
Fwd EY19.14%
FCF(TTM)0.88
FCFY17.3%
OCF(TTM)1.35
OCFY26.46%
SpS3.28
BVpS8
TBVpS-3.55
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.84%
ROE -1.71%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 77.03%
FCFM 26.98%
ROA(3y)-2.38%
ROA(5y)-3.92%
ROE(3y)-4.49%
ROE(5y)-7.98%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.07%
GM growth 5Y0.49%
F-Score7
Asset Turnover0.2
Health
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF 5.96
Debt/EBITDA 5.35
Cap/Depr 43.4%
Cap/Sales 14.29%
Interest Coverage N/A
Cash Conversion 137.28%
Profit Quality N/A
Current Ratio 3.71
Quick Ratio 3.71
Altman-Z 0.37
F-Score7
WACC6.2%
ROIC/WACCN/A
Cap/Depr(3y)47.31%
Cap/Depr(5y)41.61%
Cap/Sales(3y)16.73%
Cap/Sales(5y)15.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1.11%
EPS 3Y3.49%
EPS 5YN/A
EPS Q2Q%-4.35%
EPS Next Y-5.68%
EPS Next 2Y3.11%
EPS Next 3Y3.51%
EPS Next 5YN/A
Revenue 1Y (TTM)2.26%
Revenue growth 3Y12.6%
Revenue growth 5Y24.51%
Sales Q2Q%-4.21%
Revenue Next Year-3.49%
Revenue Next 2Y2.22%
Revenue Next 3Y3.49%
Revenue Next 5YN/A
EBIT growth 1Y50.66%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year29615.8%
EBIT Next 3Y598.57%
EBIT Next 5YN/A
FCF growth 1Y134.64%
FCF growth 3Y52.25%
FCF growth 5Y51.08%
OCF growth 1Y57.19%
OCF growth 3Y41.19%
OCF growth 5Y47.79%